Author: Hongyi Chen; Zhicheng Zhang; Li Wang; Zhihua Huang; Fanghua Gong; Xiaodong Li; Yahong Chen; Jinzi J. WU
Title: First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients Document date: 2020_3_24
ID: b3y9zxjr_6
Snippet: Chinese adult (18-75 years old in both genders) pneumonia patients with SARS-COV-2 infection confirmed to be positive by RT-PCR; demonstrated respiratory symptoms and imaging-confirmed pneumonia as defined in China National Standards; naïve patients were newly diagnosed patients who never received any antiviral treatments and danoprevir/ritonavir treatment were initiated within 7 days or less from the diagnosis; experienced patients might receiv.....
Document: Chinese adult (18-75 years old in both genders) pneumonia patients with SARS-COV-2 infection confirmed to be positive by RT-PCR; demonstrated respiratory symptoms and imaging-confirmed pneumonia as defined in China National Standards; naïve patients were newly diagnosed patients who never received any antiviral treatments and danoprevir/ritonavir treatment were initiated within 7 days or less from the diagnosis; experienced patients might receive antiviral therapies with dosage and treatment duration recommended by China National Standards [14] ; women and their partners with no planned pregnancy for 6 months after the study and willing to take effective contraceptive measures within 30 days from the first administration of the study drugs; patients agreed that they would not participate in other clinical trials within 30 days from the last administration of the study drugs; patients were willing to sign informed consent form.
Search related documents:
Co phrase search for related documents- antiviral therapy and consent form: 1
- antiviral therapy and experience patient: 1
- antiviral therapy and pneumonia patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- antiviral therapy and respiratory symptom: 1
- antiviral therapy and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- antiviral therapy and study drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- antiviral therapy and treatment dosage: 1, 2
- antiviral therapy and treatment dosage duration: 1
- antiviral treatment and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60
- antiviral treatment and consent form: 1
- antiviral treatment and danoprevir ritonavir: 1, 2
- antiviral treatment and danoprevir ritonavir treatment: 1, 2
- antiviral treatment and experience patient: 1
- antiviral treatment and informed consent form: 1
- antiviral treatment and informed consent form sign: 1
- antiviral treatment and pneumonia patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- antiviral treatment and respiratory symptom: 1, 2, 3, 4
- antiviral treatment and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- antiviral treatment and study drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
Co phrase search for related documents, hyperlinks ordered by date